Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors
City of Hope Medical Center
City of Hope Medical Center
National Cancer Institute (NCI)
Seagen Inc.
Brown University
Jonsson Comprehensive Cancer Center
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Toray Industries, Inc
Baylor College of Medicine
Eli Lilly and Company
Shanghai Junshi Bioscience Co., Ltd.
First Affiliated Hospital of Chongqing Medical University
Eli Lilly and Company
Emory University
H. Lee Moffitt Cancer Center and Research Institute
Masonic Cancer Center, University of Minnesota
Mayo Clinic
City of Hope Medical Center
European Organisation for Research and Treatment of Cancer - EORTC
Icahn School of Medicine at Mount Sinai
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
GlaxoSmithKline
M.D. Anderson Cancer Center
Mayo Clinic